These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38749360)

  • 1. Pelvic exenteration for locally advanced and recurrent prostate cancer.
    Ephraums J; Brown KGM; Solomon MJ; Austin KKS; Lee PJ; Leslie S; Byrne C
    Eur J Surg Oncol; 2024 Jul; 50(7):108384. PubMed ID: 38749360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
    Williams M; Perera M; Nouhaud FX; Coughlin G
    Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer.
    Kamat AM; Huang SF; Bermejo CE; Rosser CJ; Pettaway CA; Pisters PW; Guitreau D; Pisters LL
    J Urol; 2003 Nov; 170(5):1868-71. PubMed ID: 14532795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of using basement membrane biological products in pelvic floor reconstruction during pelvic exenteration].
    Chen GL; Wang YL; Zhang X; Tao Y; Sun YH; Chen JN; Wang SQ; Su N; Wang ZG; Zhang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):268-276. PubMed ID: 36925127
    [No Abstract]   [Full Text] [Related]  

  • 5. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
    Platt E; Dovell G; Smolarek S
    Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic exenteration surgery in patients with locally advanced castration-naïve and castration-resistant, symptomatic prostate cancer.
    Heidenreich A; Bludau M; Bruns C; Nestler T; Porres D; Pfister DJKP
    BJU Int; 2020 Sep; 126(3):342-349. PubMed ID: 32320130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
    Xin KY; Ng DW; Tan GH; Teo MC
    J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
    PelvExCollaborative
    Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.
    Huang Y; Steffens D; Koh CE; Young JM; Solomon MJ
    Dis Colon Rectum; 2022 Dec; 65(12):1475-1482. PubMed ID: 35913831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes Following Pelvic Exenteration for Locally Recurrent Rectal Cancer With and Without En Bloc Sacrectomy.
    Waller JH; van Kessel CS; Solomon MJ; Lee PJ; Austin KKS; Steffens D
    Dis Colon Rectum; 2024 Jun; 67(6):796-804. PubMed ID: 38408876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series.
    Lee PJ; Meshkat B; Sasidharan P; Zahid A; Coker DJ; Solomon MJ
    ANZ J Surg; 2022 May; 92(5):1038-1043. PubMed ID: 34661958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent Outcomes After Extended Radical Pelvic Resection for Locally Advanced and Recurrent IBD-Associated Anorectal Cancer.
    Chang KH; Brown KGM; Chen Lau Y; Solomon MJ
    Dis Colon Rectum; 2021 Feb; 64(2):209-216. PubMed ID: 33315717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
    PelvEx Collaborative
    BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
    Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
    Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
    Deng H; Wang JL; Wang ZQ; Li XW; Hu H; Yang B; Zhang XM; Shen K; Guo P; Liang B
    Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):259-265. PubMed ID: 32375433
    [No Abstract]   [Full Text] [Related]  

  • 17. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration.
    Saqib SU; Raza MZ; Twigg J; Altan O; Bajwa AA
    Langenbecks Arch Surg; 2023 Dec; 409(1):9. PubMed ID: 38102305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic exenteration combined with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for advanced primary or recurrent colorectal cancer with peritoneal metastases.
    Brown KGM; Ansari N; Solomon MJ; Austin KKS; Hamilton AER; Young CJ
    Colorectal Dis; 2021 Jan; 23(1):186-191. PubMed ID: 32978813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic multivisceral pelvic resection: experience from an exenteration unit.
    Smith N; Murphy DG; Lawrentschuk N; McCormick J; Heriot A; Warrier S; Lynch AC
    Tech Coloproctol; 2020 Nov; 24(11):1145-1153. PubMed ID: 32662050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies: A 25-Year Experience.
    Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Heriot AG; Frizelle FA; McCormick JJ
    Ann Surg Oncol; 2020 Feb; 27(2):409-414. PubMed ID: 31520213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.